 | • レポートコード：MRC2102QY5001 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、146ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の馬用医薬品・サプリメント市場について種類別（医薬品、サプリメント）、用途別（サラブレッド種、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・馬用医薬品・サプリメント市場の概要 ・世界の主要地域別馬用医薬品・サプリメント市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の馬用医薬品・サプリメント市場規模2015-2026：種類別（医薬品、サプリメント） ・世界の馬用医薬品・サプリメント市場規模2015-2026：用途別（サラブレッド種、その他） ・馬用医薬品・サプリメントの米国市場規模2015-2020 ・馬用医薬品・サプリメントのヨーロッパ市場規模2015-2020 ・馬用医薬品・サプリメントの中国市場規模2015-2020 ・馬用医薬品・サプリメントの日本市場規模2015-2020 ・馬用医薬品・サプリメントの東南アジア市場規模2015-2020 ・馬用医薬品・サプリメントのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・馬用医薬品・サプリメントの製造コスト分析 ・販売チャネル、流通業者、顧客 ・馬用医薬品・サプリメントの市場動向・機会・課題 ・調査の結論 |
Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases.
In the last several years, global market of Equine Pharmaceuticals and Supplements developed rapidly, with an average growth rate of 4.52% during 2013 to 2017. In 2017, global revenue of Equine Pharmaceuticals and Supplements is nearly 977 M USD; the actual production is about 13700 K Unit.
Market Analysis and Insights: Global Equine Pharmaceuticals and Supplements Market
The global Equine Pharmaceuticals and Supplements market size is projected to reach US$ 1528.9 million by 2026, from US$ 1174.1 million in 2020, at a CAGR of 4.5% during 2021-2026.
Global Equine Pharmaceuticals and Supplements Scope and Market Size
The global Equine Pharmaceuticals and Supplements market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Equine Pharmaceuticals and Supplements market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Equine Pharmaceuticals and Supplements market is segmented into
Pharmaceuticals
Supplements
Segment by Application, the Equine Pharmaceuticals and Supplements market is segmented into
Thoroughbred Horse
Other Types of Horses
The Equine Pharmaceuticals and Supplements market is analysed and market size information is provided by regions (countries). Segment by Application, the Equine Pharmaceuticals and Supplements market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Equine Pharmaceuticals and Supplements Market Share Analysis
Equine Pharmaceuticals and Supplements market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Equine Pharmaceuticals and Supplements business, the date to enter into the Equine Pharmaceuticals and Supplements market, Equine Pharmaceuticals and Supplements product introduction, recent developments, etc.
The major vendors covered:
Boehringer Ingelheim
Merck Animal Health
Zoetis
Bayer Animal Health
Elanco Animal Health
Dechra Veterinary Products
CEVA
Virbac
Norbrook Equine
Kyoritsu Seiyaku
Vetoquinol
Protexin Healthcare
Audevard
Ouro Fino Saude
1 Equine Pharmaceuticals and Supplements Market Overview
1.1 Equine Pharmaceuticals and Supplements Product Scope
1.2 Equine Pharmaceuticals and Supplements Segment by Type
1.2.1 Global Equine Pharmaceuticals and Supplements Sales by Type (2020-2026)
1.2.2 Pharmaceuticals
1.2.3 Supplements
1.3 Equine Pharmaceuticals and Supplements Segment by Application
1.3.1 Global Equine Pharmaceuticals and Supplements Sales Comparison by Application (2020-2026)
1.3.2 Thoroughbred Horse
1.3.3 Other Types of Horses
1.4 Equine Pharmaceuticals and Supplements Market Estimates and Forecasts (2015-2026)
1.4.1 Global Equine Pharmaceuticals and Supplements Sales Growth Rate (2015-2026)
1.4.2 Global Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2015-2026)
1.4.3 Global Equine Pharmaceuticals and Supplements Price Trends (2015-2026)
2 Equine Pharmaceuticals and Supplements Estimate and Forecast by Region
2.1 Global Equine Pharmaceuticals and Supplements Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Equine Pharmaceuticals and Supplements Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Equine Pharmaceuticals and Supplements Sales Market Share by Region (2015-2020)
2.2.2 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2015-2020)
2.3 Global Equine Pharmaceuticals and Supplements Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Equine Pharmaceuticals and Supplements Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Equine Pharmaceuticals and Supplements Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Equine Pharmaceuticals and Supplements Estimates and Projections (2015-2026)
2.4.2 Europe Equine Pharmaceuticals and Supplements Estimates and Projections (2015-2026)
2.4.3 China Equine Pharmaceuticals and Supplements Estimates and Projections (2015-2026)
2.4.4 Japan Equine Pharmaceuticals and Supplements Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Equine Pharmaceuticals and Supplements Estimates and Projections (2015-2026)
2.4.6 India Equine Pharmaceuticals and Supplements Estimates and Projections (2015-2026)
3 Global Equine Pharmaceuticals and Supplements Competition Landscape by Players
3.1 Global Top Equine Pharmaceuticals and Supplements Players by Sales (2015-2020)
3.2 Global Top Equine Pharmaceuticals and Supplements Players by Revenue (2015-2020)
3.3 Global Equine Pharmaceuticals and Supplements Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Equine Pharmaceuticals and Supplements as of 2019)
3.4 Global Equine Pharmaceuticals and Supplements Average Price by Company (2015-2020)
3.5 Manufacturers Equine Pharmaceuticals and Supplements Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Equine Pharmaceuticals and Supplements Players (Opinion Leaders)
4 Global Equine Pharmaceuticals and Supplements Market Size by Type
4.1 Global Equine Pharmaceuticals and Supplements Historic Market Review by Type (2015-2020)
4.1.1 Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2015-2020)
4.1.2 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2015-2020)
4.1.3 Global Equine Pharmaceuticals and Supplements Price by Type (2015-2020)
4.2 Global Equine Pharmaceuticals and Supplements Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Equine Pharmaceuticals and Supplements Sales Forecast by Type (2021-2026)
4.2.2 Global Equine Pharmaceuticals and Supplements Revenue Forecast by Type (2021-2026)
4.2.3 Global Equine Pharmaceuticals and Supplements Price Forecast by Type (2021-2026)
5 Global Equine Pharmaceuticals and Supplements Market Size by Application
5.1 Global Equine Pharmaceuticals and Supplements Historic Market Review by Application (2015-2020)
5.1.1 Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2015-2020)
5.1.2 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2015-2020)
5.1.3 Global Equine Pharmaceuticals and Supplements Price by Application (2015-2020)
5.2 Global Equine Pharmaceuticals and Supplements Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Equine Pharmaceuticals and Supplements Sales Forecast by Application (2021-2026)
5.2.2 Global Equine Pharmaceuticals and Supplements Revenue Forecast by Application (2021-2026)
5.2.3 Global Equine Pharmaceuticals and Supplements Price Forecast by Application (2021-2026)
6 United States Equine Pharmaceuticals and Supplements Market Facts & Figures
6.1 United States Equine Pharmaceuticals and Supplements Sales Market Share by Company (2015-2020)
6.2 United States Equine Pharmaceuticals and Supplements Sales Market Share by Type (2015-2020)
6.3 United States Equine Pharmaceuticals and Supplements Sales Market Share by Application (2015-2020)
7 Europe Equine Pharmaceuticals and Supplements Market Facts & Figures
7.1 Europe Equine Pharmaceuticals and Supplements Sales Market Share by Company (2015-2020)
7.2 Europe Equine Pharmaceuticals and Supplements Sales Market Share by Type (2015-2020)
7.3 Europe Equine Pharmaceuticals and Supplements Sales Market Share by Application (2015-2020)
8 China Equine Pharmaceuticals and Supplements Market Facts & Figures
8.1 China Equine Pharmaceuticals and Supplements Sales Market Share by Company (2015-2020)
8.2 China Equine Pharmaceuticals and Supplements Sales Market Share by Type (2015-2020)
8.3 China Equine Pharmaceuticals and Supplements Sales Market Share by Application (2015-2020)
9 Japan Equine Pharmaceuticals and Supplements Market Facts & Figures
9.1 Japan Equine Pharmaceuticals and Supplements Sales Market Share by Company (3015-3030)
9.2 Japan Equine Pharmaceuticals and Supplements Sales Market Share by Type (2015-2020)
9.3 Japan Equine Pharmaceuticals and Supplements Sales Market Share by Application (2015-2020)
10 Southeast Asia Equine Pharmaceuticals and Supplements Market Facts & Figures
10.1 Southeast Asia Equine Pharmaceuticals and Supplements Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Equine Pharmaceuticals and Supplements Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Equine Pharmaceuticals and Supplements Sales Market Share by Application (2015-2020)
11 India Equine Pharmaceuticals and Supplements Market Facts & Figures
11.1 India Equine Pharmaceuticals and Supplements Sales Market Share by Company (2015-2020)
11.2 India Equine Pharmaceuticals and Supplements Sales Market Share by Type (2015-2020)
11.3 India Equine Pharmaceuticals and Supplements Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Equine Pharmaceuticals and Supplements Business
12.1 Boehringer Ingelheim
12.1.1 Boehringer Ingelheim Corporation Information
12.1.2 Boehringer Ingelheim Business Overview
12.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Products Offered
12.1.5 Boehringer Ingelheim Recent Development
12.2 Merck Animal Health
12.2.1 Merck Animal Health Corporation Information
12.2.2 Merck Animal Health Business Overview
12.2.3 Merck Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Merck Animal Health Equine Pharmaceuticals and Supplements Products Offered
12.2.5 Merck Animal Health Recent Development
12.3 Zoetis
12.3.1 Zoetis Corporation Information
12.3.2 Zoetis Business Overview
12.3.3 Zoetis Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Zoetis Equine Pharmaceuticals and Supplements Products Offered
12.3.5 Zoetis Recent Development
12.4 Bayer Animal Health
12.4.1 Bayer Animal Health Corporation Information
12.4.2 Bayer Animal Health Business Overview
12.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Bayer Animal Health Equine Pharmaceuticals and Supplements Products Offered
12.4.5 Bayer Animal Health Recent Development
12.5 Elanco Animal Health
12.5.1 Elanco Animal Health Corporation Information
12.5.2 Elanco Animal Health Business Overview
12.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Elanco Animal Health Equine Pharmaceuticals and Supplements Products Offered
12.5.5 Elanco Animal Health Recent Development
12.6 Dechra Veterinary Products
12.6.1 Dechra Veterinary Products Corporation Information
12.6.2 Dechra Veterinary Products Business Overview
12.6.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Products Offered
12.6.5 Dechra Veterinary Products Recent Development
12.7 CEVA
12.7.1 CEVA Corporation Information
12.7.2 CEVA Business Overview
12.7.3 CEVA Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2015-2020)
12.7.4 CEVA Equine Pharmaceuticals and Supplements Products Offered
12.7.5 CEVA Recent Development
12.8 Virbac
12.8.1 Virbac Corporation Information
12.8.2 Virbac Business Overview
12.8.3 Virbac Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Virbac Equine Pharmaceuticals and Supplements Products Offered
12.8.5 Virbac Recent Development
12.9 Norbrook Equine
12.9.1 Norbrook Equine Corporation Information
12.9.2 Norbrook Equine Business Overview
12.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Norbrook Equine Equine Pharmaceuticals and Supplements Products Offered
12.9.5 Norbrook Equine Recent Development
12.10 Kyoritsu Seiyaku
12.10.1 Kyoritsu Seiyaku Corporation Information
12.10.2 Kyoritsu Seiyaku Business Overview
12.10.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Products Offered
12.10.5 Kyoritsu Seiyaku Recent Development
12.11 Vetoquinol
12.11.1 Vetoquinol Corporation Information
12.11.2 Vetoquinol Business Overview
12.11.3 Vetoquinol Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Vetoquinol Equine Pharmaceuticals and Supplements Products Offered
12.11.5 Vetoquinol Recent Development
12.12 Protexin Healthcare
12.12.1 Protexin Healthcare Corporation Information
12.12.2 Protexin Healthcare Business Overview
12.12.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Protexin Healthcare Equine Pharmaceuticals and Supplements Products Offered
12.12.5 Protexin Healthcare Recent Development
12.13 Audevard
12.13.1 Audevard Corporation Information
12.13.2 Audevard Business Overview
12.13.3 Audevard Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Audevard Equine Pharmaceuticals and Supplements Products Offered
12.13.5 Audevard Recent Development
12.14 Ouro Fino Saude
12.14.1 Ouro Fino Saude Corporation Information
12.14.2 Ouro Fino Saude Business Overview
12.14.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Ouro Fino Saude Equine Pharmaceuticals and Supplements Products Offered
12.14.5 Ouro Fino Saude Recent Development
13 Equine Pharmaceuticals and Supplements Manufacturing Cost Analysis
13.1 Equine Pharmaceuticals and Supplements Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Equine Pharmaceuticals and Supplements
13.4 Equine Pharmaceuticals and Supplements Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Equine Pharmaceuticals and Supplements Distributors List
14.3 Equine Pharmaceuticals and Supplements Customers
15 Market Dynamics
15.1 Equine Pharmaceuticals and Supplements Market Trends
15.2 Equine Pharmaceuticals and Supplements Opportunities and Drivers
15.3 Equine Pharmaceuticals and Supplements Market Challenges
15.4 Equine Pharmaceuticals and Supplements Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Equine Pharmaceuticals and Supplements Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Equine Pharmaceuticals and Supplements Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Equine Pharmaceuticals and Supplements Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Equine Pharmaceuticals and Supplements Sales (K Units) by Region (2015-2020)
Table 5. Global Equine Pharmaceuticals and Supplements Sales Market Share by Region (2015-2020)
Table 6. Global Equine Pharmaceuticals and Supplements Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Equine Pharmaceuticals and Supplements Revenue Share by Region (2015-2020)
Table 8. Global Equine Pharmaceuticals and Supplements Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Equine Pharmaceuticals and Supplements Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Equine Pharmaceuticals and Supplements Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Equine Pharmaceuticals and Supplements Revenue Share Forecast by Region (2021-2026)
Table 12. Global Equine Pharmaceuticals and Supplements (K Units) of Key Companies (2015-2020)
Table 13. Global Equine Pharmaceuticals and Supplements Sales Share by Company (2015-2020)
Table 14. Global Equine Pharmaceuticals and Supplements Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Equine Pharmaceuticals and Supplements Revenue Share by Company (2015-2020)
Table 16. Global Equine Pharmaceuticals and Supplements by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Equine Pharmaceuticals and Supplements as of 2019)
Table 17. Global Equine Pharmaceuticals and Supplements Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Equine Pharmaceuticals and Supplements Manufacturing Sites and Area Served
Table 19. Manufacturers Equine Pharmaceuticals and Supplements Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Equine Pharmaceuticals and Supplements Players
Table 22. Global Equine Pharmaceuticals and Supplements Sales (K Units) by Type (2015-2020)
Table 23. Global Equine Pharmaceuticals and Supplements Sales Share by Type (2015-2020)
Table 24. Global Equine Pharmaceuticals and Supplements Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Equine Pharmaceuticals and Supplements Price (K Units) by Type (2015-2020)
Table 26. Global Equine Pharmaceuticals and Supplements Sales Share by Type (2021-2026)
Table 27. Global Equine Pharmaceuticals and Supplements Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Equine Pharmaceuticals and Supplements Revenue Share by Type (2021-2026)
Table 29. Global Equine Pharmaceuticals and Supplements Price (K Units) by Type (2021-2026)
Table 30. Global Equine Pharmaceuticals and Supplements Sales (K Units) by Application (2015-2020)
Table 31. Global Equine Pharmaceuticals and Supplements Sales Share by Application (2015-2020)
Table 32. Global Equine Pharmaceuticals and Supplements Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Equine Pharmaceuticals and Supplements Price (K Units) by Application (2015-2020)
Table 34. Global Equine Pharmaceuticals and Supplements Sales (K Units) by Application (2021-2026)
Table 35. Global Equine Pharmaceuticals and Supplements Sales Share by Application (2021-2026)
Table 36. Global Equine Pharmaceuticals and Supplements Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Equine Pharmaceuticals and Supplements Revenue Share by Application (2021-2026)
Table 38. Global Equine Pharmaceuticals and Supplements Price (K Units) by Application (2021-2026)
Table 39. United States Equine Pharmaceuticals and Supplements Sales (K Units) by Company (2015-2020)
Table 40. United States Equine Pharmaceuticals and Supplements Sales Market Share by Company (2015-2020)
Table 41. United States Equine Pharmaceuticals and Supplements Sales (K Units) by Type (2015-2020)
Table 42. United States Equine Pharmaceuticals and Supplements Sales Market Share by Type (2015-2020)
Table 43. United States Equine Pharmaceuticals and Supplements Sales (K Units) by Application (2015-2020)
Table 44. United States Equine Pharmaceuticals and Supplements Sales Market Share by Application (2015-2020)
Table 45. Europe Equine Pharmaceuticals and Supplements Sales (K Units) by Company (2015-2020)
Table 46. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Company (2015-2020)
Table 47. Europe Equine Pharmaceuticals and Supplements Sales (K Units) by Type (2015-2020)
Table 48. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Type (2015-2020)
Table 49. Europe Equine Pharmaceuticals and Supplements Sales (K Units) by Application (2015-2020)
Table 50. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Type (2015-2020)
Table 51. China Equine Pharmaceuticals and Supplements Sales (K Units) by Company (2015-2020)
Table 52. China Equine Pharmaceuticals and Supplements Sales Market Share by Company (2015-2020)
Table 53. China Equine Pharmaceuticals and Supplements Sales (K Units) by Type (2015-2020)
Table 54. China Equine Pharmaceuticals and Supplements Sales Market Share by Type (2015-2020)
Table 55. China Equine Pharmaceuticals and Supplements Sales (K Units) by Application (2015-2020)
Table 56. China Equine Pharmaceuticals and Supplements Sales Market Share by Application (2015-2020)
Table 57. Japan Equine Pharmaceuticals and Supplements Sales (K Units) by Company (2015-2020)
Table 58. Japan Equine Pharmaceuticals and Supplements Sales Market Share by Company (2015-2020)
Table 59. Japan Equine Pharmaceuticals and Supplements Sales (K Units) by Type (2015-2020)
Table 60. Japan Equine Pharmaceuticals and Supplements Sales Market Share by Type (2015-2020)
Table 61. Japan Equine Pharmaceuticals and Supplements Sales (K Units) by Application (2015-2020)
Table 62. Japan Equine Pharmaceuticals and Supplements Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Equine Pharmaceuticals and Supplements Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Equine Pharmaceuticals and Supplements Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Equine Pharmaceuticals and Supplements Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Equine Pharmaceuticals and Supplements Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Equine Pharmaceuticals and Supplements Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Equine Pharmaceuticals and Supplements Sales Market Share by Application (2015-2020)
Table 69. India Equine Pharmaceuticals and Supplements Sales (K Units) by Company (2015-2020)
Table 70. India Equine Pharmaceuticals and Supplements Sales Market Share by Company (2015-2020)
Table 71. India Equine Pharmaceuticals and Supplements Sales (K Units) by Type (2015-2020)
Table 72. India Equine Pharmaceuticals and Supplements Sales Market Share by Type (2015-2020)
Table 73. India Equine Pharmaceuticals and Supplements Sales (K Units) by Application (2015-2020)
Table 74. India Equine Pharmaceuticals and Supplements Sales Market Share by Application (2015-2020)
Table 75. Boehringer Ingelheim Corporation Information
Table 76. Boehringer Ingelheim Description and Business Overview
Table 77. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product
Table 79. Boehringer Ingelheim Recent Development
Table 80. Merck Animal Health Corporation Information
Table 81. Merck Animal Health Description and Business Overview
Table 82. Merck Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Merck Animal Health Equine Pharmaceuticals and Supplements Product
Table 84. Merck Animal Health Recent Development
Table 85. Zoetis Corporation Information
Table 86. Zoetis Description and Business Overview
Table 87. Zoetis Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Zoetis Equine Pharmaceuticals and Supplements Product
Table 89. Zoetis Recent Development
Table 90. Bayer Animal Health Corporation Information
Table 91. Bayer Animal Health Description and Business Overview
Table 92. Bayer Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Bayer Animal Health Equine Pharmaceuticals and Supplements Product
Table 94. Bayer Animal Health Recent Development
Table 95. Elanco Animal Health Corporation Information
Table 96. Elanco Animal Health Description and Business Overview
Table 97. Elanco Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Elanco Animal Health Equine Pharmaceuticals and Supplements Product
Table 99. Elanco Animal Health Recent Development
Table 100. Dechra Veterinary Products Corporation Information
Table 101. Dechra Veterinary Products Description and Business Overview
Table 102. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product
Table 104. Dechra Veterinary Products Recent Development
Table 105. CEVA Corporation Information
Table 106. CEVA Description and Business Overview
Table 107. CEVA Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. CEVA Equine Pharmaceuticals and Supplements Product
Table 109. CEVA Recent Development
Table 110. Virbac Corporation Information
Table 111. Virbac Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Virbac Description and Business Overview
Table 113. Virbac Equine Pharmaceuticals and Supplements Product
Table 114. Virbac Recent Development
Table 115. Norbrook Equine Corporation Information
Table 116. Norbrook Equine Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Norbrook Equine Description and Business Overview
Table 118. Norbrook Equine Equine Pharmaceuticals and Supplements Product
Table 119. Norbrook Equine Recent Development
Table 120. Kyoritsu Seiyaku Corporation Information
Table 121. Kyoritsu Seiyaku Description and Business Overview
Table 122. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product
Table 124. Kyoritsu Seiyaku Recent Development
Table 125. Vetoquinol Corporation Information
Table 126. Vetoquinol Description and Business Overview
Table 127. Vetoquinol Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Vetoquinol Equine Pharmaceuticals and Supplements Product
Table 129. Vetoquinol Recent Development
Table 130. Protexin Healthcare Corporation Information
Table 131. Protexin Healthcare Description and Business Overview
Table 132. Protexin Healthcare Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Protexin Healthcare Equine Pharmaceuticals and Supplements Product
Table 134. Protexin Healthcare Recent Development
Table 135. Audevard Corporation Information
Table 136. Audevard Description and Business Overview
Table 137. Audevard Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Audevard Equine Pharmaceuticals and Supplements Product
Table 139. Audevard Recent Development
Table 140. Ouro Fino Saude Corporation Information
Table 141. Ouro Fino Saude Description and Business Overview
Table 142. Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. Ouro Fino Saude Equine Pharmaceuticals and Supplements Product
Table 144. Ouro Fino Saude Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. Equine Pharmaceuticals and Supplements Distributors List
Table 148. Equine Pharmaceuticals and Supplements Customers List
Table 149. Equine Pharmaceuticals and Supplements Market Key Trends
Table 150. Equine Pharmaceuticals and Supplements Key Opportunities and Drivers
Table 151. Equine Pharmaceuticals and Supplements Market Challenges
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Equine Pharmaceuticals and Supplements Product Picture
Figure 2. Global Equine Pharmaceuticals and Supplements Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Equine Pharmaceuticals and Supplements Market Share by Application in 2020 & 2026
Figure 6. Thoroughbred Horse Examples
Figure 7. Other Types of Horses Examples
Figure 8. Global Equine Pharmaceuticals and Supplements Sales (K Units) Growth Rate (2015-2026)
Figure 9. Global Equine Pharmaceuticals and Supplements Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Equine Pharmaceuticals and Supplements Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 11. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Equine Pharmaceuticals and Supplements Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Equine Pharmaceuticals and Supplements Sales (K Units) Growth Rate (2015-2026)
Figure 15. Europe Equine Pharmaceuticals and Supplements Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Equine Pharmaceuticals and Supplements Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Equine Pharmaceuticals and Supplements Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Equine Pharmaceuticals and Supplements Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Equine Pharmaceuticals and Supplements Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Equine Pharmaceuticals and Supplements Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Equine Pharmaceuticals and Supplements Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Equine Pharmaceuticals and Supplements Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Equine Pharmaceuticals and Supplements Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Equine Pharmaceuticals and Supplements Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Equine Pharmaceuticals and Supplements Players Market Share by Revenue in Equine Pharmaceuticals and Supplements 2015 & 2019
Figure 26. Equine Pharmaceuticals and Supplements Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Equine Pharmaceuticals and Supplements Revenue Share by Type (2015-2020)
Figure 28. Global Equine Pharmaceuticals and Supplements Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Equine Pharmaceuticals and Supplements Revenue Share by Application (2015-2020)
Figure 30. Global Equine Pharmaceuticals and Supplements Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Equine Pharmaceuticals and Supplements Sales Market Share by Type in 2019
Figure 32. United States Equine Pharmaceuticals and Supplements Sales Market Share by Type in 2019
Figure 33. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Company in 2019
Figure 34. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Type in 2019
Figure 35. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Application in 2019
Figure 36. China Equine Pharmaceuticals and Supplements Sales Market Share by Company in 2019
Figure 37. China Equine Pharmaceuticals and Supplements Sales Market Share by Type in 2019
Figure 38. China Equine Pharmaceuticals and Supplements Sales Market Share by Application in 2019
Figure 39. Japan Equine Pharmaceuticals and Supplements Sales Market Share by Company in 2019
Figure 40. Japan Equine Pharmaceuticals and Supplements Sales Market Share by Type in 2019
Figure 41. Japan Equine Pharmaceuticals and Supplements Sales Market Share by Application in 2019
Figure 42. Southeast Asia Equine Pharmaceuticals and Supplements Sales Market Share by Company in 2019
Figure 43. Southeast Asia Equine Pharmaceuticals and Supplements Sales Market Share by Type in 2019
Figure 44. Southeast Asia Equine Pharmaceuticals and Supplements Sales Market Share by Application in 2019
Figure 45. India Equine Pharmaceuticals and Supplements Sales Market Share by Company in 2019
Figure 46. India Equine Pharmaceuticals and Supplements Sales Market Share by Type in 2019
Figure 47. India Equine Pharmaceuticals and Supplements Sales Market Share by Application in 2019
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Equine Pharmaceuticals and Supplements
Figure 50. Manufacturing Process Analysis of Equine Pharmaceuticals and Supplements
Figure 51. Equine Pharmaceuticals and Supplements Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Porter's Five Forces Analysis
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
精力増強サプリメントの世界市場レポート2020 This report studies the Sexual Enhancement Supplements market, Sexual Enhancement Supplements work by increasing the amount of blood flow the genital region receives and the volume of blood that it can retain. The Sexual Enhancement Supplements consumption volume was 1640 K Units in 2016 and is expe…- ビタミン・サプリメントの世界市場レポート2020 Market Analysis and Insights: Global Vitamins & Supplements Market The global Vitamins & Supplements market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Vitamins & Supplements Scope and Market Size The global Vitamins & Sup…
- 栄養・栄養補助食品の世界市場レポート2020 Market Analysis and Insights: Global Nutritional & Dietary Supplements Market The global Nutritional & Dietary Supplements market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Nutritional & Dietary Supplements Scope and Mark…
- スポーツ・健康栄養補助食品の世界市場レポート2020 Sports nutrition products are used to enhance athletic performance that may include vitamins, minerals, amino acids, herbs, or botanicals (plants) -- or any concentration, extract, or combination of these. Sports nutrition products can be categorized as food, beverage or supplements. In this report,…
- 胎盤の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Placenta is the vascular organ in most mammals that connects the fetus to the uterus of the mother. It mediates the metabolic exchanges of the developing individual through an intimate association of embryonic tissues and of specific uterine tissues, which serve the functions of respiration, nutriti…